The intravenous pharmacokinetics of butorphanol and detomidine dosed in combination compared with individual dose administrations to exercised horses.

The research explores how the combination of two drugs, butorphanol and detomidine, commonly used in horse racing and equestrian practice for their sedative properties, affects their pharmacokinetics in horses’ bodies. The study was aimed at providing better clarity to veterinary surgeons in Europe, by providing detection times. The findings indicate differing clearance rates and half-lives for each drug when administered alone versus in combination, suggesting that detection times of 72 and 48 hours are ideal for butorphanol and detomidine, respectively.

Objective and Methodology

• The study aimed to establish detection times for butorphanol and detomidine in horse racing and equestrian competitions to help veterinary surgeons in Europe use these drugs appropriately under regulatory rules.
• The research involved three independent groups of horses receiving varying dosages of butorphanol, detomidine, or a combination of both. The dosages were assessed using intravenous administration.
• The concentrations of both drugs, as well as 3-hydroxydetomidine (a detomidine metabolite), were measured in plasma and urine at pre-determined time points using the very accurate LC-MS/MS method (liquid chromatography-tandem mass spectrometry).

Findings

• Butorphanol, when dosed individually, was cleared at roughly double the rate compared with co-administration with detomidine but exhibited similar half-life (the time it takes for the drug concentration to reduce by half).
• Detomidine’s clearance rate and half-life were similar when it was administered alone and in combination with butorphanol.
• Metabolite 3-hyroxydetomidine was detected in urine for at least 35 hours for both single and co-administration administrations.
• Recommendations for detection time (period during which the drug concentrations in the body remain at levels that can be detected in testing) were 72 hours for butorphanol and 48 hours for detomidine.

Significance

• The findings of the study are significant as they provide crucial data to plan the use of such sedatives effectively while conforming to the regulatory rules, thereby eliminating the risks of unintentional doping in equestrian sports.
• Understanding the pharmacokinetics of medications in animals is vital for veterinarians to ensure proper dosing and timing, aiding effective management of the animal’s health and improving their performance in competitive scenarios.